Stock & Company Details
GRI Bio Inc $GRI
Price:
46,691,331
1.8M
$3.1M
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
0.00
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Investment Trust/Mutual Fund
GRI technical indicators
Latest GRI Bio Inc (GRI) technical indicators as of 2026-07-01: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
38.10 1.5%
MACD:
-0.10 6.0%
SMA 50:
$2.15 0.7%
SMA 200:
$1.94 0.0%
EMA 20:
$1.99 1.1%
Bollinger Bands:
2.43 / 1.65
Stochastic:
14.16 7.7%
ADX 14:
29.69 4.7%
ATR 14:
0.16 1.1%
CCI 20:
-107.17 6.8%
OBV:
52.14M 0.1%
ROC 12:
-20.89% 10.6%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis.
Finance Bot
Ask your questions
Start by typing a question below.
